Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
9.42
+0.49 (5.49%)
At close: Jun 26, 2026, 4:00 PM EDT
9.30
-0.12 (-1.27%)
After-hours: Jun 26, 2026, 7:29 PM EDT
Cartesian Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Cartesian Therapeutics stock have an average target of 33.83, with a low estimate of 16 and a high estimate of 44. The average target predicts an increase of 259.13% from the current stock price of 9.42.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cartesian Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 7 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $38 | Buy | Maintains | $38 | +303.40% | Jun 11, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $40 | Buy | Reiterates | $40 | +324.63% | Jun 10, 2026 |
| BTIG | BTIG | Buy Reiterates $44 | Buy | Reiterates | $44 | +367.09% | Jun 9, 2026 |
| Needham | Needham | Buy Reiterates $40 | Buy | Reiterates | $40 | +324.63% | Jun 9, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 27, 2026 |
Financial Forecast
Revenue This Year
552.25K
from 2.80M
Decreased by -80.26%
Revenue Next Year
401.50K
from 552.25K
Decreased by -27.30%
EPS This Year
-3.35
from -4.99
EPS Next Year
-2.68
from -3.35
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.9M | 1.9M | |
| Avg | 552,250 | 401,500 | |
| Low | 78,000 | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -32.1% | 244.0% | |
| Avg | -80.3% | -27.3% | |
| Low | -97.2% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.35 | -2.68 | |
| Avg | -3.35 | -2.68 | |
| Low | -3.35 | -2.68 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.